WCM Investment Management Portfolio holdings
AUM
$43.8B
1-Year Return
46.92%
This Quarter Return
+13.17%
1 Year Return
+46.92%
3 Year Return
+145.55%
5 Year Return
+234.7%
10 Year Return
+793.48%
AUM
$18.6B
AUM Growth
+$1.94B
(+12%)
Cap. Flow
+$139M
Cap. Flow
% of AUM
0.75%
Top 10 Holdings %
Top 10 Hldgs %
70.09%
Holding
166
New
14
Increased
113
Reduced
26
Closed
9
Top Buys
| 1 |
lululemon athletica
LULU
|
$763M |
| 2 |
ASML
ASML
|
$150M |
| 3 |
Intercontinental Exchange
ICE
|
$109M |
| 4 |
Church & Dwight Co
CHD
|
$105M |
| 5 |
Smith & Nephew
SNN
|
$78.4M |
Top Sells
| 1 |
Chubb
CB
|
$1.24B |
| 2 |
Agilent Technologies
A
|
$104M |
| 3 |
Charles Schwab
SCHW
|
$78.4M |
| 4 |
Boston Scientific
BSX
|
$62.6M |
| 5 |
Steris
STE
|
$54.9M |
Sector Composition
| 1 | Technology | 35.28% |
| 2 | Healthcare | 23.99% |
| 3 | Financials | 16.5% |
| 4 | Industrials | 11.01% |
| 5 | Consumer Discretionary | 6.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
126
Dave & Buster's
PLAY
$820M
| $4.18M | 0.02% |
104,126
+75,807
| +268% | +$3.05M |
|
127
Credicorp
BAP
$20.7B
| $4.15M | 0.02% |
19,477
+2,808
| +17% | +$598K |
|
128
Rogers Corp
ROG
$1.43B
| $4.07M | 0.02% |
32,590
+23,659
| +265% | +$2.95M |
|
129
Telkom Indonesia
TLK
$19.2B
| $3.97M | 0.02% |
139,254
+20,150
| +17% | +$574K |
|
130
Globant
GLOB
$2.78B
| $3.72M | 0.02% |
35,039
+5,070
| +17% | +$538K |
|
131
Iovance Biotherapeutics
IOVA
$901M
| $3.68M | 0.02% |
132,894
+111,611
| +524% | +$3.09M |
|
|
SWAV
132
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
| $3.6M | 0.02% |
81,936
+62,719
| +326% | +$2.75M |
|
133
Repligen
RGEN
$7.01B
| $3.47M | 0.02% |
37,536
+27,484
| +273% | +$2.54M |
|
134
Teladoc Health
TDOC
$1.38B
| $3.26M | 0.02% |
38,919
+20,454
| +111% | +$1.71M |
|
135
AtriCure
ATRC
$1.76B
| $3.19M | 0.02% |
98,136
+74,893
| +322% | +$2.43M |
|
|
BPMC
136
DELISTED
Blueprint Medicines
BPMC
| $2.99M | 0.02% |
37,339
+31,844
| +580% | +$2.55M |
|
137
Acadia Pharmaceuticals
ACAD
$4.26B
| $2.97M | 0.02% |
69,426
+56,750
| +448% | +$2.43M |
|
138
XP
XP
$9.96B
| $2.85M | 0.02% |
+74,070
| New | +$2.85M |
|
139
Natera
NTRA
$23.1B
| $2.76M | 0.01% |
+81,873
| New | +$2.76M |
|
140
Ligand Pharmaceuticals
LGND
$3.25B
| $2.49M | 0.01% |
38,227
+28,880
| +309% | +$1.88M |
|
141
Halozyme
HALO
$8.76B
| $2.44M | 0.01% |
137,428
+105,916
| +336% | +$1.88M |
|
142
iShares MSCI India ETF
INDA
$9.26B
| $2.32M | 0.01% |
65,940
+59,930
| +997% | +$2.11M |
|
|
BHVN
143
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $2.3M | 0.01% |
42,289
+26,481
| +168% | +$1.44M |
|
144
Kura Oncology
KURA
$713M
| $2.29M | 0.01% |
166,774
+147,780
| +778% | +$2.03M |
|
145
Arrowhead Research
ARWR
$4.02B
| $2.15M | 0.01% |
+33,910
| New | +$2.15M |
|
146
Amazon
AMZN
$2.48T
| $1.96M | 0.01% |
21,240
| – | – |
|
|
RETA
147
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $1.72M | 0.01% |
8,419
+2,110
| +33% | +$431K |
|
148
Synopsys
SNPS
$111B
| $1.71M | 0.01% |
12,273
+133
| +1% | +$18.5K |
|
149
FibroGen
FGEN
$48.9M
| $1.66M | 0.01% |
1,548
+1,188
| +330% | +$1.27M |
|
|
ZGNX
150
DELISTED
Zogenix, Inc.
ZGNX
| $1.63M | 0.01% |
+31,264
| New | +$1.63M |
|